These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1628876)

  • 1. The role of monoamine oxidase in the metabolism of exogenous noradrenaline by the human saphenous vein.
    Branco D; Caramona M; Araújo D; Osswald W
    Fundam Clin Pharmacol; 1992; 6(3):145-52. PubMed ID: 1628876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominance of oxidative deamination in the metabolism of exogenous noradrenaline by the normal and chemically denervated human uterine artery.
    Branco D; Caramona M; Martel F; de Almeida JA; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):286-93. PubMed ID: 1407015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deamination of released 3H-noradrenaline in the canine saphenous vein.
    Verbeuren TJ; Vanhoutte PM
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):148-57. PubMed ID: 7063044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative deamination of noradrenaline in human blood vessels.
    Osswald W
    J Neural Transm Suppl; 1990; 32():395-404. PubMed ID: 2089103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of MAO-A and MAO-B in the metabolic degradation of noradrenaline in human arteries.
    Figueiredo IV; Caramona M; Paiva MQ; Guimarães S
    J Auton Pharmacol; 1998 Apr; 18(2):123-8. PubMed ID: 9730267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of MAO A and MAO B on the inactivation of noradrenaline in the saphenous vein of the dog.
    Caramona MM; Araújo D; Brandão F
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):401-6. PubMed ID: 3921856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of clorgyline and (-)deprenyl on the deamination of normetanephrine and noradrenaline in strips and homogenates of the canine saphenous vein.
    Caramona MM; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):396-400. PubMed ID: 3921855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuronal and extraneuronal uptake and metabolism of 3H-(-)-noradrenaline in the perfused rat heart.
    Fiebig ER; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1978 May; 303(1):21-35. PubMed ID: 673014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake and metabolism of 3H-adrenaline and 3H-noradrenaline by isolated hepatocytes and liver slices of the rat.
    Martel F; Azevedo I; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):450-7. PubMed ID: 8114943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats.
    Eisenhofer G; Finberg JP
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1242-51. PubMed ID: 8138937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine oxidase of types A and B in the saphenous vein and mesenteric artery of the dog.
    Caramona MM
    Naunyn Schmiedebergs Arch Pharmacol; 1982 May; 319(2):121-4. PubMed ID: 7110373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the concentration of noradrenaline at the neuro-effector junction in human saphenous vein.
    Janssens W; Verhaeghe R
    Br J Pharmacol; 1983 Jun; 79(2):577-85. PubMed ID: 6317115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norepinephrine metabolism in canine saphenous vein: prevalence of glycol metabolites.
    Muldoon SM; Vanhoutte PM; Tyce GM
    Am J Physiol; 1978 Mar; 234(3):H235-43. PubMed ID: 629360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of [3H]-noradrenaline in human dental pulp in vitro.
    Parker DA; de la Lande IS; Marino V; Proctor CH; Ivar PM; Parker I
    Arch Oral Biol; 1994 Jan; 39(1):43-9. PubMed ID: 8179507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the metabolic fate of noradrenaline released by electrical stimulation or by tyramine.
    Brandão F; Monteiro JG; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct; 305(1):37-40. PubMed ID: 723969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake and metabolism of noradrenaline by blood vessels of perinephritic hypertensive dogs.
    Garrett J; Castro-Tavares J; Branco D
    Blood Vessels; 1981; 18(3):100-9. PubMed ID: 7225573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of norepinephrine in an isolated vein.
    Brandao F
    J Pharmacol Exp Ther; 1977 Oct; 203(1):23-9. PubMed ID: 909054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a monoamine oxidase A inhibitor, FLA 668 (+) on the adrenergic mechanisms of the dog saphenous vein.
    Caramona MM; Esplugues JV; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):181-5. PubMed ID: 2935741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release and disposition of 3H-noradrenaline in the saphenous vein of neonate and adult dogs.
    Moura D; Vaz-da-Silva MJ; Azevedo I; Brandão F; Guimarães S
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Feb; 347(2):186-91. PubMed ID: 8474538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ovarian steroids on the metabolism of noradrenaline in rabbit uterus.
    Kennedy JA; de la Lande IS; Morris RG
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun; 326(2):132-42. PubMed ID: 6472491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.